Cargando…
A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma
Tumor microenvironment (TME) plays a crucial role in predicting prognosis and response to therapy in lung cancer. Our study established a prognostic and immunotherapeutic predictive model, the tumor immune cell score (TICS), by differentiating cell origins in lung adenocarcinoma (LUAD) based on the...
Autores principales: | Xu, Jiachen, Yang, Zhenlin, Xie, Wenchuan, Wan, Rui, Li, Chengcheng, Fei, Kailun, Sun, Boyang, Yang, Xu, Chen, Ping, Meng, Fanqi, Wang, Guoqiang, Zhao, Jing, Han, Yusheng, Cai, Shangli, Wang, Jie, Wang, Zhijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165414/ https://www.ncbi.nlm.nih.gov/pubmed/37168563 http://dx.doi.org/10.1016/j.isci.2023.106616 |
Ejemplares similares
-
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
por: Bai, Hua, et al.
Publicado: (2020) -
IMPACT: A web server for exploring immunotherapeutic predictive and cancer prognostic biomarkers
por: Liu, Yutao, et al.
Publicado: (2023) -
Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021) -
The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
por: Zhang, Yong, et al.
Publicado: (2022) -
Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
por: Xu, Jun, et al.
Publicado: (2023)